We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+5.12%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$5.78B
AUM Growth
+$56.1M
Cap. Flow
-$188M
Cap. Flow %
-3.26%
Top 10 Hldgs %
16.17%
Holding
795
New
72
Increased
310
Reduced
286
Closed
45

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$28.5M
2
META icon
Meta Platforms (Facebook)
META
+$26M
3
TRV icon
Travelers Companies
TRV
+$17.1M
4
LUV icon
Southwest Airlines
LUV
+$16.6M
5
CI icon
Cigna
CI
+$16.6M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$76.5M
2
JNJ icon
Johnson & Johnson
JNJ
+$27.8M
3
GILD icon
Gilead Sciences
GILD
+$26.5M
4
CPB icon
Campbell Soup
CPB
+$20.6M
5
AMZN icon
Amazon
AMZN
+$20.2M

Sector Composition

Rank Sector Weight
1 Healthcare 22.62%
2 Technology 14.65%
3 Financials 14.55%
4 Consumer Discretionary 9.89%
5 Communication Services 9.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JEF icon
251
Jefferies Financial Group
JEF
$12.9B
$5.53M 0.1%
+233,394
New +$5.38M
J icon
252
Jacobs Solutions
J
$15.9B
$5.48M 0.09%
+100,450
New +$5.15M
MZOR
253
DELISTED
Mazor Robotics Ltd.
MZOR
$5.47M 0.09%
106,097
-52,955
-33% -$2.98M
ORLY icon
254
O'Reilly Automotive
ORLY
$72.4B
$5.44M 0.09%
339,450
+246,390
+265% +$3.67M
NEE icon
255
NextEra Energy
NEE
$187B
$5.43M 0.09%
139,172
+8,072
+6% +$312K
RVNC
256
DELISTED
Revance Therapeutics, Inc.
RVNC
$5.4M 0.09%
151,000
+15,000
+11% +$431K
EXEL icon
257
Exelixis
EXEL
$13.9B
$5.3M 0.09%
174,500
-27,500
-14% -$732K
FLR icon
258
Fluor
FLR
$7.29B
$5.23M 0.09%
101,238
+81,746
+419% +$3.81M
AET
259
DELISTED
Aetna Inc
AET
$5.12M 0.09%
28,396
+985
+4% +$169K
AMD icon
260
Advanced Micro Devices
AMD
$851B
$5.11M 0.09%
496,831
+450,174
+965% +$5.26M
ALB icon
261
Albemarle
ALB
$13.5B
$5.1M 0.09%
39,858
+2,387
+6% +$324K
WMB icon
262
Williams Companies
WMB
$90.5B
$5.07M 0.09%
166,164
-73,097
-31% -$2.13M
LPT
263
DELISTED
Liberty Property Trust
LPT
$5.02M 0.09%
116,671
+81,117
+228% +$3.52M
DHR icon
264
Danaher
DHR
$135B
$4.95M 0.09%
60,161
-74,319
-55% -$6.04M
VFC icon
265
VF Corp
VFC
$6.68B
$4.92M 0.09%
70,537
+24,437
+53% +$1.61M
CNC icon
266
Centene
CNC
$31.3B
$4.88M 0.08%
96,774
-62,240
-39% -$3.02M
TGT icon
267
Target
TGT
$62.1B
$4.86M 0.08%
74,477
-2,945
-4% -$178K
MNTA
268
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$4.84M 0.08%
347,000
-75,000
-18% -$1.01M
CHTR icon
269
Charter Communications
CHTR
$14.7B
$4.84M 0.08%
14,400
-408
-3% -$139K
SPGI icon
270
S&P Global
SPGI
$126B
$4.83M 0.08%
28,544
+3,264
+13% +$533K
HOG icon
271
Harley-Davidson
HOG
$2.68B
$4.82M 0.08%
94,666
+5,497
+6% +$267K
RIGL icon
272
Rigel Pharmaceuticals
RIGL
$680M
$4.73M 0.08%
122,000
-4,500
-4% -$171K
MXIM
273
DELISTED
Maxim Integrated Products
MXIM
$4.69M 0.08%
+89,663
New +$4.66M
EL icon
274
Estee Lauder
EL
$29B
$4.68M 0.08%
36,759
-74,951
-67% -$9M
MAR icon
275
Marriott International
MAR
$98.7B
$4.63M 0.08%
34,082
+1,745
+5% +$214K
9 10
11
12 13

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2017 Portfolio in Review

As of Q4 2017, Candriam SCA held 795 positions worth $5.78B, up 0.98% from $5.72B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Candriam SCA withdrew a net $188M in Q4 2017, closing 45 positions and reducing 286 holdings. Its most notable exit was Hubbell, an estimated $11.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 27% a quarter earlier, followed by Technology and Financials.

Against the trend, Candriam SCA opened a new position in 58.com Inc worth $15.6M.

  • Candriam SCA's largest Q4 2017 buy was 58.com Inc: 218,000 shares worth $15.6M.
  • Candriam SCA added most to Amgen in Q4 2017, an estimated $28.5M increase.
  • Candriam SCA's biggest Q4 2017 reduction was Biogen, cutting an estimated $76.5M.
  • Candriam SCA fully exited Hubbell in Q4 2017, selling an estimated $11.1M.
  • Candriam SCA's ten largest holdings make up 16% of its $5.78B portfolio in Q4 2017.
  • Candriam SCA opened 72 new positions and closed 45 in Q4 2017.
  • Candriam SCA's portfolio value rose 0.98% quarter-over-quarter to $5.78B.

Based on Candriam SCA's 13F filing for Q4 2017, filed 7 Feb 2018.